Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,258 | -26,259 | -40,257 | -35,842 | -47,511 |
| Depreciation Amortization | 2,331 | 3,741 | 2,422 | 1,815 | 1,959 |
| Accounts receivable | -5,794 | 3,422 | -3,170 | -5,158 | -3,352 |
| Accounts payable and accrued liabilities | -1,715 | 1,149 | 1,066 | 1,491 | -1,540 |
| Other Working Capital | 1,890 | -6,830 | -5,461 | -1,938 | -2,046 |
| Other Operating Activity | 13,322 | 4,810 | 24,312 | 12,790 | 26,604 |
| Operating Cash Flow | $-29,224 | $-19,967 | $-21,088 | $-26,842 | $-25,886 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,887 | -8,432 | -4,527 | N/A | N/A |
| PPE Investments | -223 | -204 | -5,474 | -8,935 | -1,499 |
| Net Acquisitions | -1,370 | N/A | -2,898 | -86 | -6,401 |
| Sale Of Investment | 467 | N/A | 37,622 | N/A | N/A |
| Purchase Sale Intangibles | 483 | -2,037 | N/A | 0 | 2,700 |
| Other Investing Activity | 483 | -1,037 | 6,436 | -11,670 | -12,819 |
| Investing Cash Flow | $11,244 | $-9,673 | $31,159 | $-20,691 | $-20,719 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,001 | 709 | 1,249 |
| Debt Repayment | N/A | N/A | -4,001 | -1,548 | N/A |
| Common Stock Issued | 17,112 | 109 | N/A | 32,500 | 48,973 |
| Common Stock Repurchased | N/A | -278 | -3,267 | N/A | N/A |
| Dividend Paid | -718 | -738 | N/A | N/A | N/A |
| Other Financing Activity | -960 | 0 | 0 | -2,019 | -3,069 |
| Financing Cash Flow | $15,434 | $-907 | $-3,267 | $29,642 | $47,153 |
| Exchange Rate Effect | -1,069 | 518 | 1,604 | -469 | 2,895 |
| Beginning Cash Position | 17,083 | 47,112 | 38,704 | 57,064 | 53,621 |
| End Cash Position | 13,468 | 17,083 | 47,112 | 38,704 | 57,064 |
| Net Cash Flow | $-3,615 | $-30,029 | $8,408 | $-18,360 | $3,443 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,224 | -19,967 | -21,088 | -26,842 | -25,886 |
| Capital Expenditure | -223 | -204 | -5,612 | -8,945 | -1,499 |
| Free Cash Flow | -29,447 | -20,171 | -26,700 | -35,787 | -27,385 |